A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America

Abstract

Flexible-dose pregabalin (150-600 mg/day) significantly reduced pain and anxiety and improved sleep and was generally well tolerated in Latin American patients with neuropathic pain.